AUD 0.05
(6.52%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 9.63 Million AUD | 44.27% |
2022 | 9.13 Million USD | -10.98% |
2021 | 10.26 Million AUD | 2.74% |
2020 | 9.99 Million AUD | -32.01% |
2019 | 14.69 Million AUD | -13.11% |
2018 | 16.91 Million AUD | 30.81% |
2017 | 12.92 Million AUD | 184.2% |
2016 | 4.54 Million AUD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 Q2 | 2.44 Million USD | 0.37% |
2023 Q3 | 2.44 Million USD | 0.02% |
2023 FY | 13.18 Million AUD | 44.27% |
2023 Q4 | 2.31 Million USD | -5.68% |
2023 Q1 | 2.43 Million USD | 23.81% |
2022 Q3 | 2.09 Million USD | -9.75% |
2022 Q4 | 1.97 Million USD | -6.05% |
2022 FY | 9.13 Million USD | -10.98% |
2022 Q2 | 2.32 Million USD | 0.0% |
2021 FY | 10.26 Million AUD | 2.74% |
2020 FY | 9.99 Million AUD | -32.01% |
2019 Q2 | 746.5 Thousand AUD | 0.0% |
2019 Q1 | 746.5 Thousand AUD | 0.0% |
2019 FY | 14.69 Million AUD | -13.11% |
2018 Q1 | 926.96 Thousand AUD | 0.0% |
2018 FY | 16.91 Million AUD | 30.81% |
2018 Q4 | 746.5 Thousand AUD | 0.0% |
2018 Q2 | 926.96 Thousand AUD | 0.0% |
2017 Q1 | 483.65 Thousand AUD | 0.0% |
2017 Q2 | 483.65 Thousand AUD | 0.0% |
2017 Q4 | - AUD | 0.0% |
2017 FY | 12.92 Million AUD | 184.2% |
2016 Q2 | - AUD | 0.0% |
2016 Q1 | - AUD | 0.0% |
2016 Q4 | 483.65 Thousand AUD | 0.0% |
2016 FY | 4.54 Million AUD | 0.0% |
2015 Q4 | - AUD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
4DMedical Limited | 31.48 Million AUD | 69.401% |
Adherium Limited | 267.7 Thousand AUD | -3498.628% |
Aroa Biosurgery Limited | 66.09 Million AUD | 85.426% |
Atomo Diagnostics Limited | 1.6 Million AUD | -499.852% |
Anteris Technologies Ltd | 69.14 Million AUD | 86.068% |
Control Bionics Limited | 9.82 Million AUD | 1.957% |
CardieX Limited | 16.64 Million AUD | 42.137% |
Compumedics Limited | 26.88 Million AUD | 64.161% |
Cochlear Limited | 1.17 Billion AUD | 99.18% |
CleanSpace Holdings Limited | 11.35 Million AUD | 15.192% |
Cyclopharm Limited | 13.38 Million AUD | 28.004% |
EMVision Medical Devices Ltd | 12.83 Million AUD | 24.934% |
Nova Eye Medical Limited | 23.99 Million AUD | 59.843% |
HeraMED Limited | 6.78 Million AUD | -42.027% |
Imricor Medical Systems, Inc. | -1.11 Million AUD | 963.354% |
ImpediMed Limited | 28.04 Million AUD | 65.644% |
InhaleRx Limited | 2.59 Million AUD | -271.879% |
LBT Innovations Limited | 1.1 Million AUD | -770.247% |
Micro-X Limited | 18.76 Million AUD | 48.659% |
Neurotech International Limited | 8.75 Million AUD | -10.045% |
OncoSil Medical Limited | 12.03 Million AUD | 19.985% |
PolyNovo Limited | 34.92 Million AUD | 72.414% |
Respiri Limited | 8.03 Million AUD | -19.898% |
SomnoMed Limited | 58.97 Million AUD | 83.664% |
Universal Biosensors, Inc. | 20 Million AUD | 51.832% |
Uscom Limited | 5.52 Million AUD | -74.521% |